OR WAIT 15 SECS
© 2021 MJH Life Sciences and Pharmaceutical Technology. All rights reserved.
© 2021 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
January 02, 2021
The incoming administration faces key decisions on drug testing and access as well as vaccine distribution challenges.
December 02, 2020
Manufacturers and regulators accelerate R&D and production of new vaccines and therapies.
November 23, 2020
The Trump administration unveiled a new drug price control policy, drawing opposition from pharma manufacturers and pharmacy benefit managers.
October 09, 2020
Bio/pharma industry leaders support FDA’s newly published EUA guidance for COVID-19 vaccine authorization.
October 02, 2020
Drug shortages and supply chain challenges bolster FDA efforts to promote modern manufacturing.
September 02, 2020
Regulators strive to review flood of advanced treatments while also vetting COVID-19 vaccines.
July 01, 2020
FDA can better monitor quality production of domestic versus foreign firms.
May 02, 2020
Policy makers seek to ensure supplies of new therapies and to limit shortages.
April 02, 2020
FDA is encouraging alternative insulins and challenging anticompetitive practices.
March 02, 2020
States, hospitals, and insurers support manufacturing arrangements to ensure access to affordable medicines.